Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Endoscopic electroporation with bleomycin in esophageal and gastroesophageal junction cancer
2015-005246-59Phase 2Terminated
- Sponsor
- Michael Patrick Achiam
- Start
- Feb 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of bleomycin in esophageal cancer and esophagogastric junction cancer, sponsored by Michael Patrick Achiam. Primary endpoint: Safety and feasibility. Started Feb 2016; status: terminated.
02
Drugs
bleomycin
03
Conditions
esophageal canceresophagogastric junction cancer
Beyond the preview
Go deeper on 2015-005246-59.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-005246-59.